The blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center, without affecting other brain regions among people with Alzheimer's disease. These findings indicate that the known decrease in cerebral blood flow in patients with Alzheimer's can be reversed in some regions. However, it is unclear if this translates to clinical benefits.
from Latest Science News -- ScienceDaily http://bit.ly/2ILOJQb
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment